Fig. 2
From: The synergistic mechanisms of propofol with cisplatin or doxorubicin in human ovarian cancer cells
Assessment of the impact of propofol on the colony-forming capability of human ovarian cancer cells. SKOV3 and OVCAR3 cells were exposed to varying concentrations of propofol (0, 20, 30, and 40 µg/ml) for a duration of 14 days. The bars represent the mean ± SD of three independent experiments. Statistical significance is indicated by * for p < 0.05, ** for p < 0.01, and *** for p < 0.001, determined using Student’s t-tests